Efficacy and Safety of Lomitapide in Hypercholesterolemia.
Liu X, Men P, Wang Y, Zhai S, Zhao Z, Liu G.
Am J Cardiovasc Drugs · review; journal article · DOI 10.1007/s40256-017-0214-7 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för lomitapide. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
20 träffarLomitapide for the treatment of hypercholesterolemia.
Berberich AJ, Hegele RA.
Expert Opin Pharmacother · review; journal article · DOI 10.1080/14656566.2017.1340941Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.
Blom DJ, Averna MR, Meagher EA, du Toit Theron H, Sirtori CR, Hegele RA, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Larrey D, Bloedon LT, Foulds P, Rader DJ, Cuchel M.
Circulation · letter; research support, non-u.s. gov't · DOI 10.1161/circulationaha.117.028208Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy.
D'Erasmo L, Cefalù AB, Noto D, Giammanco A, Averna M, Pintus P, Medde P, Vigna GB, Sirtori C, Calabresi L, Pavanello C, Bucci M, Sabbà C, Suppressa P, Natale F, Calabrò P, Sampietro T, Bigazzi F, Sbrana F, Bonomo K, Sileo F, Arca M.
Adv Ther · journal article · DOI 10.1007/s12325-017-0531-xA First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them.
Yoshida H.
J Atheroscler Thromb · editorial; journal article · DOI 10.5551/jat.ed069Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia.
Harada-Shiba M, Ikewaki K, Nohara A, Otsubo Y, Yanagi K, Yoshida M, Chang Q, Foulds P.
J Atheroscler Thromb · clinical trial, phase iii; research-article; journal article · DOI 10.5551/jat.38216Lomitapide for the treatment of hypertriglyceridemia.
Brahm AJ, Hegele RA.
Expert Opin Investig Drugs · review; journal article; case reports · DOI 10.1080/13543784.2016.1254187Lomitapide affects HDL composition and function.
Yahya R, Favari E, Calabresi L, Verhoeven AJM, Zimetti F, Adorni MP, Gomaraschi M, Averna M, Cefalù AB, Bernini F, Sijbrands EJG, Mulder MT, Roeters van Lennep JE.
Atherosclerosis · journal article · DOI 10.1016/j.atherosclerosis.2016.05.005Pharmacokinetics and Pharmacodynamics of Lomitapide in Japanese Subjects.
Taubel J, Sumeray M, Lorch U, McLean A.
J Atheroscler Thromb · clinical trial, phase i; randomized controlled trial; journal article · DOI 10.5551/jat.30452LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design.
Blom DJ, Fayad ZA, Kastelein JJ, Larrey D, Makris L, Schwamlein C, Bloeden L, Underberg J, LOWER investigators.
J Clin Lipidol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jacl.2015.11.011Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects.
Patel G, King A, Dutta S, Korb S, Wade JR, Foulds P, Sumeray M.
J Clin Pharmacol · clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1002/jcph.581Lomitapide.
Goulooze SC, Cohen AF, Rissmann R.
Br J Clin Pharmacol · research-article; journal article · DOI 10.1111/bcp.12612Clinical experience of lomitapide therapy in patients with homozygous familial hypercholesterolaemia.
Cuchel M, Blom DJ, Averna MR.
Atheroscler Suppl · review; journal article; case reports · DOI 10.1016/j.atherosclerosissup.2014.07.005Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide.
Sacks FM, Stanesa M, Hegele RA.
JAMA Intern Med · journal article; case reports · DOI 10.1001/jamainternmed.2013.13309Lomitapide for homozygous familial hypercholesterolaemia.
Raal FJ.
Lancet · comment; journal article · DOI 10.1016/s0140-6736(12)61845-5Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.
Cuchel M, Meagher EA, du Toit Theron H, Blom DJ, Marais AD, Hegele RA, Averna MR, Sirtori CR, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Du Plessis AM, Propert KJ, Sasiela WJ, Bloedon LT, Rader DJ, Phase 3 HoFH Lomitapide Study investigators.
Lancet · clinical trial, phase iii; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; multicenter study; journal article; research support, n.i.h., extramural · DOI 10.1016/s0140-6736(12)61731-0New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.
Stefanutti C, Morozzi C, Di Giacomo S.
Curr Med Chem · review; journal article · DOI 10.2174/092986712803341485Lomitapide.
Författaruppgift saknas
Am J Cardiovasc Drugs · review; journal article · DOI 10.2165/11533560-000000000-00000Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia.
Rizzo M.
IDrugs · review; journal articleInhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ.
N Engl J Med · clinical trial; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1056/nejmoa061189